Recent FDA review process of inconclusive clinical studies creates a potentially unhealthy decision-making environment for patients needing gadolinium-enhanced MRIs.
Orest Boyko, MD, PhD
Advertisement
Articles by Orest Boyko, MD, PhD
Advertisement
Latest Updated Articles
U.S. Patients Left Fending For Themselves with Gadolinium Safety RisksPublished: December 11th 2017 | Updated:
Advertisement
Advertisement
